Maahantuomme ravintolisiä USA: sta, FDA: n tiukasti valvomilta markkinoilta.
Visionamme on tuottaa oikeaa tietoa terveyden uhkatekijöistä.
Suurimpana ongelmana länsimaissa on jatkuva, yksipuolisesti liian hapan ruokavalio, jota elimistö ei kykene riittävästi puskuroimaan, vaan koko aineenvaihdunta -järjestelmä joutuu tekemään työtä happamuutta vastaan.
Lopulta elimistö alkaa tulehtua ja saavuttaa potilaan huomaamatta, jatkuvan tulehduksellisen tilan.
Gaza: Hospitals receive 38 martyrs, death toll climbs to 53,977 | 26-May-2025
US gave Israel $21.7 billion in military aid during Gaza conflict | 7 Oct, 2025.
TRUMP-NETANYAHU’s Devilish Fake Truce in GAZA | Oct 24, 2025
Haplogroup J1 - The Generations of Noah - Gaza Semites | 9th Jan, 2026 - J1-P58, the Central Semitic branch of J1, appears to have expanded from the southern Levant (Israel, Palestine, Jordan) across the Arabian peninsula during the Bronze Age. - About 20% of Jewish people belong haplogroup J1-P58. - In the Hebrew Bible, the common ancestor of all Cohens is identified as Aaron, the brother of Moses. - Roughly half (50%) of all Cohanim belong to J1-ZS227. - The acclaimed Jewish actor and director Dustin Hoffman appears to belongs to haplogroup J1-Z18271, which corresponds to the lineage of the Y-chromosomal Aaron. - Arabs (Palestine Muslim) - AA (Semitic) - 55.2%, Nebel 2001[2] - Arabs (Palestine Christian) - AA (Semitic) - 9,0%, Fernandes 2011[15].
T=1768293797 / Human Date and time (GMT): Tue. 13th Jan. 2026, 08.43
___
Israel’s Biggest Con Trick: Hiding the True Numbers It Has Killed in Gaza
Israel has penned us all into a ‘debate’, one entirely divorced from reality, that relates only to those killed directly by its bombs and gunfire – not the genocide it is waging by other means
The biggest con trick Israel has managed to pull off over the past two years is imposing entirely phoney parameters on a “debate” in the West about the credibility of the death toll in Gaza, now officially standing at just over 70,000.
It is not just that we have been endlessly bogged down in rows about whether Gaza’s medical authorities can be trusted, or how many of the dead are Hamas fighters. (Despite Israeli disinformation campaigns, the Israeli military itself believes more than 80 per cent of the dead are civilians.)
Or even that these “debates” always ignore the fact that, early on, Israel wrecked Gaza’s capacity to count its dead by destroying the enclave’s governmental offices and its hospitals. The 70,000 figure is likely to be a drastic under-estimate.
No, the biggest con trick is that Israel has successfully penned us all into a “debate”, one entirely divorced from reality, that relates only to those killed directly by its bombs and gunfire.
The truth is that far, far larger numbers of people in Gaza have been actively killed by Israel not through these direct means but through what statisticians refer to as “indirect” methods.
These people were killed by Israel destroying their homes and leaving them with no shelter. By Israel destroying their water and electricity supplies and their sanitation systems. By Israel levelling their hospitals. By Israel starving them. By Israel creating the perfect conditions for disease to spread. The list of ways Israel is killing people in Gaza goes on and on.
Imagine your own societies levelled in the way Gaza has been.
How long would your elderly parents survive in this hellscape?
How well would your diabetic child fare, or your sister with asthma, or your brother with cancer?
How well would you cope with catching pneumonia, or even a common cold, if you hadn’t had more than one small meal a day for months on end?
How would your wife deal with a difficult childbirth if there were no anaesthetics, or no hospital nearby, or a barely functioning hospital overwhelmed with victims from Israel’s latest bombing run.
And what would be the chances of your baby surviving if its mother could produce no milk from her starvation diet? And if you could not give the baby formula feed because Israel was blocking supplies from entry into the enclave? And if, anyway, the contaminated water supply could not be mixed into the formula powder?
None of these kinds of deaths are included in the figure of 70,000. And all precedents show that many, many times more people are killed through these indirect methods than directly through fatal injuries from bombs and bullets.
According to a letter from experts in this field to the Lancet, studies of other wars – most of them far less destructive than Israel’s on the tiny enclave – indicate that between three and 15 times more people are killed by indirect, rather than direct, methods of warfare.
The authors conservatively estimate an indirect death toll four times greater than the direct death toll. That would mean, at a minimum, 350,000 Palestinians have been killed in Gaza through Israel’s actions.
The reality is likely to be even worse. That is without even mentioning the hundreds of thousands of Palestinians who have been left with horrific injuries and psychological trauma.
Israel’s war planners know exactly how this direct-to-indirect ratio works. Which is why they chose to destroy nearly every home in Gaza, to bomb the power, sanitation and water facilities, to level the hospitals, and to block aid month after month.
They knew this would be the way Israel could carry out a genocide while offering its allies – western governments and its army of lobbyists – a “get out of jail card” for their active complicity.
Donald Trump’s so-called “ceasefire” is just another layer of deception in this endless game of smoke and mirrors. The UN’s child protection agency, Unicef, reports that less than a quarter of aid trucks are getting into Gaza, past Israel’s continuing starvation blockade, despite Israeli commitments agreed as part of the “ceasefire”. Apparently, this doesn’t register as a gross ceasefire violation. It goes unnoticed.
Unicef reports further that in October alone, at the start of the “ceasefire”, nearly 18,000 new mothers and babies had to be hospitalised in Gaza from acute malnutrition.
The genocide isn’t over. Israel may have slowed the rate of direct killings it is committing by bombing Gaza, but the indirect killings continue unabated. And so does the Israeli-engineered “debate” in the West, one designed to obscure and excuse the mass murder of Gaza’s population.
(Republished from Jonathan Cook by permission of author or representative)
T=1768078253 / Human Date and time (GMT): Sat, 10th Jan, 2026, 20.50
___
BREAKING STUDY: Anomalous Amyloid Microclots Found in 100% of the COVID-19 Vaccinated
In a cohort that was 94% vaccinated, every participant had amyloid microclots —the same pathology behind the large white fibrous clots now being pulled from corpses worldwide.
A new peer-reviewed study has quietly revealed one of the most consequential biological findings of the pandemic era — and the authors never acknowledge it: Every single vaccinated participant in the study had fibrinolysis-resistant, ThT-positive amyloid microclots circulating in their blood.
Hidden in the supplementary tables is a demographic and biochemical pattern that completely reframes the paper:
94% of all participants were vaccinated. 100% of these vaccinated individuals had amyloid microclots — including every “healthy control.”
The condition labeled “Long COVID” occurred almost entirely in a heavily vaccinated population, without any laboratory confirmation of prior SARS-CoV-2 infection. In reality, the study is observing Long VACCINE pathology, not Long COVID.
And because the authors’ own mechanistic experiments show that purified spike protein alone produces these amyloid, fibrinolysis-resistant clots, the implications are profound.
Researchers identified microclots using Thioflavin-T (ThT), an amyloid-binding fluorogenic dye. ThT positivity was the defining criterion. A structure was only counted as a microclot if it bound ThT.
Therefore, every microclot counted in the study is, by definition, amyloidogenic.
And according to Table S11, every single vaccinated participant had amyloid microclots in multiple size ranges:
Because 83 of 88 participants (94%) were vaccinated, this means:
Every vaccinated person in the study had amyloid microclots.
“Long COVID” (Long VACCINE) patients had extreme elevations in large, pathological amyloid microclots
Small amyloid microclots were present in everyone, but the pathological burden differed sharply.
According to Table S11:
98% of “Long COVID” (Long VACCINE) patients had large microclots in the 900–1600 µm² range
60% had very large microclots >1600 µm²
Total microclot burden was ~20-fold higher in “Long COVID” patients
These larger, pathogenic amyloid microclots were densely packed with:
Neutrophil extracellular traps (NETs)
Myeloperoxidase
Neutrophil elastase
Extracellular DNA
Misfolded amyloid fibrin
COVID-19 infection was never verified
Despite positioning the results as a hallmark of “Long COVID,” none of the participants were confirmed to have had SARS-CoV-2 infection. The study performed:
no antibody testing
no PCR
no sequencing
no neutralizing antibody assays
Long COVID status was assigned purely via symptoms and clinician impression. There is no evidence in the study that any participant was biologically positive for prior infection.
Thus, the clotting abnormalities cannot be attributed specifically to infection, but rather to vaccination.
Spike protein alone produced identical amyloid microclots
In a mechanistic experiment, the authors added purified spike protein to fibrinogen.
This single intervention produced:
insoluble, ThT-positive amyloid microclots
misfolded fibrin structures identical to those in patient samples
fibrinolysis-resistant aggregates compatible with vessel obstruction
The authors confirmed that Spike protein directly induces amyloid microclot formation, corroborating previous studies.
Explains prevalent white fibrous clots found in the dead
The study’s core findings — 100% amyloid microclots in vaccinated individuals and direct spike-induced amyloid fibrin formation — offer a clear mechanism for the large, rubbery white fibrous clots increasingly reported in deceased individuals since 2021.
At the 2025 Tennessee Funeral Directors Association (TFDA) convention, former USAF Major Tom Haviland conducted the first state-level survey of embalmers:
These characteristics match exactly the pathological microclots described in the new study — only at a later, aggregated, end-stage form.
The progression is biologically straightforward:
Spike exposure (infection or mRNA vaccination)
Amyloid microclots form — present in 100% of vaccinated subjects
Large, NET-rich, fibrinolysis-resistant clots accumulate (20× higher in Long vaccine patients)
These merge into massive, rubbery, white fibrous intravascular clots
This new study documents the early and intermediate stages in the living; Haviland’s surveys and McCairn’s analysis reveals the final stage in the dead.
Conclusions
Although the authors frame their findings as “Long COVID,” the underlying data reveal something far more consequential:
100% of vaccinated participants had amyloid microclots.
Large, fibrinolysis-resistant amyloid microclots were concentrated in the Long vaccine group.
No participant had laboratory-confirmed SARS-CoV-2 infection.
Spike protein alone produced identical amyloid microclots in vitro.
With 94% vaccination uptake, the biological signal is overwhelmingly linked to spike exposure in a vaccinated population.
These findings carry serious public-health implications:
Every vaccinated individual in the study showed early-stage amyloid microclots, raising alarms about cumulative vascular injury across the entire globe.
The pathology mirrors the large white fibrous clots now documented by embalmers and forensic analysts.
And critically:
The CDC and federal public-health agencies must finally do their job and launch an immediate, transparent investigation into these findings.
Failing to intestigate the white fibrous clot situation constitutes a dereliction of duty.
Any platform delivering spike protein into human circulation must be immediately banned for human use.
FOCAL POINTS (Courageous Discourse) is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Kevin W. McCairn, Ph.D., Kevin McKernan Ph.D., Shojiro Kato M.D., Charles Rixey retired (USMC-CBRN)
Abstract This report presents a preliminary forensic analysis of anomalous fibrin-like aggregates recovered from postmortem human cadaveric samples. Through a combination of gross morphological inspection, cryosection histology, fluorescent staining, scanning electron microscopy (SEM), elemental analysis (EDX), real-time PCR, Raman spectroscopy, and Real-Time Quaking-Induced Conversion (RT-QuIC), the samples were examined for biochemical and ultrastructural features associated with amyloidogenic and protease-resistant fibrin formation. Findings suggest that the clot samples exhibit hallmarks of abnormal protein aggregation consistent with pathological fibrin remodeling, including enhanced autofluorescence, beta-sheet rich domains, dense fibrillar ultrastructure, and spectral anomalies. PCR confirmed the human origin of the tissues, and preliminary evidence of molecular markers associated with recombinant spike protein exposure (SV40 & Ori) was observed. Limitations of provenance, sample control, and chain-of-custody are acknowledged, and further investigation is recommended to establish clinical, pathological, and etiological relevance.
Introduction Recent reports have drawn attention to the presence of large, rubbery, white fibrin-like clots recovered from postmortem human vasculature. These structures have been described anecdotally by embalmers and morticians and have raised questions regarding their origin, composition, and potential pathological significance. In response, this investigative effort sought to apply rigorous analytical methodologies to determine whether these samples represent a known thrombotic phenotype or reflect novel features associated with emergent pathologies.
It is now broadly recognized that SARS-CoV-2 infection can exert systemic effects beyond its respiratory tropism, with evidence pointing to persistent coagulopathy and fibrin dysregulation. Of particular concern is the potential of the viral spike protein—whether introduced via infection or recombinant delivery platforms such as LNP-mRNA vaccines—to catalyze the formation of amyloid-like fibrin clots. Prior studies have demonstrated that spike exposure can induce fibrin(ogen) conformational changes that resist fibrinolysis and exhibit beta-sheet structures akin to amyloid fibrils.
This report investigates whether the cadaver-derived clots under study bear the morphological and biochemical hallmarks of such aberrant fibrin. Key research questions include: Are the structures of human origin? Do they exhibit features consistent with amyloidogenesis? Can they be differentiated from conventional fibrin emboli or white clots found in known medical conditions?
Through a multidisciplinary forensic approach, this document catalogs the physical and biochemical attributes of the clot specimens, aiming to provide a transparent, methodologically sound foundation for independent review. Given the limitations of the sampling context and absence of complete clinical background, the findings presented here are exploratory and intended to prompt further controlled research.
Section 1: Gross Morphology of Clot Structures Image: Slides 1–5 Initial macroscopic inspection of the cadaver-derived clot specimens revealed strikingly anomalous morphology. The samples appear rubbery, fibrous, and frequently coiled or banded—bearing superficial resemblance to marine calamari. Unlike conventional thrombi, these aggregates lack the red-brown coloration and laminar erythrocyte-rich stratification commonly observed in postmortem clots.
Images collected at 4K resolution under dissecting microscope conditions show that the structures retain a solid, tensile integrity. The specimens resist tearing, do not collapse under moderate compression, and maintain structural coherence when manipulated, suggesting a composition distinct from typical fibrin gels. Internal cross-sections show a dense, layered architecture without clear vascular lumens, further differentiating them from vessel-associated thrombi.
These morphological traits suggest either advanced cross-linking within a protein matrix or a structurally aberrant form of polymerized fibrin. The preserved integrity and resistance to manipulation raise the possibility of amyloidogenic remodeling—a hypothesis explored in the following sections through microscopic and spectroscopic analysis.
Section 2: Histology and Fluorescent Imaging of Cryosections Image: Slides 6–11 Tissue samples were cryosectioned at 20 µm thickness and subjected to light and fluorescence microscopy at both 4X and 40X magnification. Hematoxylin-free imaging reveals a heterogeneous, fibrous internal structure with numerous cavities and layered fibrillar regions.
Fluorescence analysis prior to staining revealed strong and uniform intrinsic autofluorescence. Under blue-light excitation, green emission was observed; excitation in the green channel induced red fluorescence. This broad-spectrum response is highly atypical and suggests a high degree of intrinsic molecular ordering or aromatic residue stacking. Such behavior is consistent with cross-linked protein networks or amyloid-like interactions involving tyrosine, tryptophan, or phenylalanine residues.
Thioflavin T (ThT) staining was used to assess the presence of beta-sheet rich amyloid domains. Comparative imaging before and after ThT application revealed discrete "polka-dot" fluorescent foci, as well as diffuse interspersed fluorescence. These data indicate that amyloidogenic stacking is localized but not homogeneous, suggesting microclot heterogeneity within the sample.
Section 3: Scanning Electron Microscopy (SEM) and Elemental Composition via EDX Image: Slides 12–17 Cryosections of 5 µm thickness were prepared for SEM. At low magnification (25X), overall morphology was assessed. Higher magnifications (up to 5000X) revealed a dense reticular meshwork of fibrillar aggregates.
These fibrils display nodular topography and branching interconnections, consistent with pathological protein assembly. Notably, a rotational twist and lateral aggregation features were observed, hallmarks of amyloid fibrin architecture. These ultrastructural findings support the hypothesis that the observed material is not simple polymerized fibrin but instead a protease-resistant, misfolded protein aggregate.
Elemental mapping via EDX revealed high abundance of carbon, nitrogen, oxygen, and sulfur—consistent with proteinaceous material. No significant signal was detected for heavy metals (e.g., Fe, Zn, Cu), ruling out mineral-based aggregation or contamination. The absence of inorganic nucleation points supports an endogenous biochemical origin.
Section 4: PCR and Raman Spectroscopy for Tissue and Molecular Signature Image: Slides 18-20 PCR using primers for the human RNaseP transcript confirmed that the clot-derived samples were of human origin. Additional assays targeting spike protein coding sequences and plasmid-related markers (SV40, Ori) revealed late-cycle amplification, consistent with trace residual presence of recombinant vaccine components. These findings are preliminary and require cautious interpretation.
Raman spectroscopy revealed a major spectral peak at ~1720 cm⁻¹, diverging from the canonical amyloid beta-sheet signature near 1670 cm⁻¹. This spectral upshift may reflect altered secondary structure, ester linkage formation, or protonation of acidic residues. The results point to an atypical fibril composition that may represent a novel polymorph or hybrid aggregate class.
Section 5: RT-QuIC Seeding Activity in Plasma Extracts RT-QuIC analysis was used to assess seeding potential of the clot-associated material. 3D bar plot visualization of fluorescence intensity across a 96-well plate revealed elevated ThT signal in experimental wells, consistent with fibril formation, when challenged against human plasma.
However, background signal, handling artifacts, and absence of dilution series limit interpretation. Without kinetic rate modeling and control seeding, the data remain suggestive but inconclusive for prion-like activity.
Conclusion The clot structures described herein exhibit abnormal morphological, histological, ultrastructural, and spectroscopic features. Their dense fibrillar architecture, autofluorescence, ThT reactivity, spectral shifts, and preliminary RT-QuIC activity suggest amyloidogenic remodeling of fibrin under unknown conditions.
While the findings are not definitive, they raise substantial biosafety and pathophysiological questions that warrant immediate, controlled follow-up. The uncertain provenance and unstandardized collection methodology underscore the need for independent replication with verified chain-of-custody.
In the current context of vaccine-induced spike protein exposure and post-infectious complications, these results may point to a novel or under-recognized pathology. As such, they constitute a call for interdisciplinary scientific inquiry, clinical vigilance, and transparent investigation.
Slides
Slide1: A view of the samples as received, under argon (LHS) or formalin, the dissection of the argon stabilized clot was conducted using a laboratory grade dissecting microscope where images were collected at 4K resolution.
Slide 2 shows a sample extracted from the tube and pinned to the dissection area using two 30-gauge hypodermic needles.
Slide 3: Shows the specimen under the dissecting microscope, there are several surface features which are present, including fissures and striations, and there appears to be a laminar type of architecture that is difficult to discern without magnification.
Slide 4: Shows the clot after cutting with a scalpel blade, at this scale of magnification the specimen has a solid appearance and lacks the necessary lumen were it a functional part of the vasculature.
Slide 5: Shows another section of the clot after cutting with a scalpel blade, and the intensity of the lighting changed to highlight the solid appearance through the structure, and of the cut face.
Slide 6: Showing the Cryostat used to section the tissue in question and the samples after cutting mounted to a standard glass slide.
Slide 7: Low power magnification (4X) shows that the tissue is far from the solid tissue as first observed in the dissecting microscope, there are numerous cavities, and beginning of a fibrous appearance.
Slide 8: At higher magnification (40X) under normal light microscopy conditions a fibrous and matted appearance becomes the obvious feature.
Slide 9: An example of the near uniform autofluorescence observed from the sample, under a blue fluorescence source, which causes it to fluoresce in the green spectrum.
Slides 10 Show side by side comparison of the tissue in autofluorescence mode and after histological staining with ThT (left hand side), at (4X) magnification there is a distinct polka-dot appearance of areas that have taken up ThT relative to its surroundings, this would indicate that these are regions in which the amyloid stacking has occurred and are perhaps the microclots that have been reported in previous studies.
Slides 11 There is, however, a strong uptake of dye in the intervening space between areas of high concentration suggesting that these regions contain amyloidogenic material as well, this is most evident in the higher (40X) times magnification range.
Slide 12: We now transition from using light and fluorescent microscopy to SEM, the first image (25X) allows us to orientate ourselves to the specimen which fills the lower half of the image.
Slide 13: Transitioning to a higher magnification, we are now moving beyond the capabilities of light microscopy and one fiber of the clot forms the image in this slide. A nodular appearance, transposed onto linear topology begins to become apparent at this scale of magnification.
Slide 14: At 1000X magnification a complex topology, becomes apparent, linear forms can be seen to form branching interconnects of varying thickness, with globular forms also apparent. These structures are the fibrillar forms of amyloidogenic protein.
Slide 15: This high-magnification SEM image highlights the pathological ultrastructure characteristic of amyloid fibrin formation. Central to the view is a primary fibril exhibiting a distinct, rapid rotational twist, indicative of abnormal helical pathology, often associated with protease resistance and altered mechanical properties. Surrounding the main fibril, numerous nodular and bulbous formations are visible, consistent with lateral aggregation and nucleation points typical of amyloidogenic remodeling. The exaggerated torsional features and nodular morphology reflect profound alterations from normal fibrin architecture, emphasizing the pathological assembly process associated with disease states.
Slide 16: Spatial EDX mapping. This EDX map displays the spatial distribution of elemental composition across a fibrillar clot sample using SEM12,000× magnification. Each color corresponds to a specific element as indicated in the legend: carbon (C, red), oxygen (O, green), silicon (Si, blue), chlorine (Cl, cyan), sodium (Na, pink), magnesium (Mg, purple), aluminum (Al, magenta), calcium (Ca, yellow), phosphorus (P, orange), sulfur (S, light green), and nitrogen (N, lime). The widespread presence of carbon, oxygen, nitrogen, and sulfur suggests an organic matrix consistent with proteinaceous material. Notably, there is a lack of signal for transition or heavy metals (e.g., iron, zinc, copper, tin, or lead), implying that the fibrillar aggregation in this clot is not metal-driven. This distinguishes the composition from classic environmentally induced or metal-catalyzed pathological inclusions and supports a hypothesis of endogenous, possibly spike driven, protein misfolding and deposition. The uniform distribution of biogenic elements (C, N, O, S, P) further reinforces the organic and likely proteinaceous origin of the structure.
Slide 17: Quantitative EDX spectra of clot aggregates demonstrating elemental composition and absence of heavy or transition metals. EDX spectra reveals the predominance of light elements such as carbon (C), oxygen (O), sodium (Na), magnesium (Mg), phosphorus (P), sulfur (S), chlorine (Cl), potassium (K), and calcium (Ca). Notably, the absence of peaks corresponding to transition or heavy metals rules out contamination from environmental or industrial sources and suggests that the dense morphology is not due to mineralization. The abundance of Ca and Mg relative to trace elements may be relevant to charge stabilization or cross-linking mechanisms typical of amyloid fibrils. These findings support the interpretation that the clot aggregates are proteinaceous and not metal-derived in origin.
Slide 18; PCR Results for detection of human tissue using primers for detection of human RNaseP, this confirms that the tissue is of human origin
Slide 19: qPCR amplification plots demonstrating detection of human reference genes (RNAP), viral spike sequences, and plasmid vector markers (SV40 and Ori) from clot-derived tissue extracts. Amplification curves show positive detection of RNAP confirming the human origin of the sample. Late-cycle amplification signals for SV40 promoter, spike protein coding sequence, and Ori (origin of replication) suggest low-abundance presence of residual plasmid DNA consistent with LNP-based recombinant vaccine components. Controls were included for all primer sets. These results indicate preliminary molecular evidence for incorporation or association of spike vaccine-related material within the clot matrices.
Slide 20 :Raman spectroscopy of clot-derived samples showing a shifted amyloid peak.Panel A (left inset) illustrates comparative Raman signatures for reference amyloidogenic proteins, including Aβ₁₋₄₀, ApoCIII, and α-synuclein (Flyn & Lee 2018). Spectra from clot-derived material (right panels – screen capture from Reinshaw WiRE) exhibit a prominent peak near 1720 cm⁻¹, deviating from the canonical β-sheet amyloid peak at ~1670 cm⁻¹. This spectral shift may indicate altered secondary structure, chemical modification, or complexation of the fibrils within the clot. The elevation in counts and sharpness of the signal confirm that amyloid burden is both present and conformationally distinct from standard protein fibrils.
Slide 21: RT-QuIC plate reactivity heatmap for clot-derived plasma samples. 3D bar plot visualization of RT-QuIC assay output demonstrates spatial variation in sample reactivity across a 96-well plate (Screen Capture from BMG MARS Software). The vertical height and color saturation represent relative fluorescence intensity, indicative of ThT-binding to fibrillar products formed during the reaction. Elevated signals in two wells (B12 & D12) challenged with human plasma, the remaining wells are combination of various recombinant peptides in buffer solution); the specific reactive wells suggest seeding-competent material consistent with amyloidogenic or prion-like activity. Control wells (Rows A & H) remain low, supporting the specificity of reactivity to experimental samples. This assay provides preliminary evidence of templated misfolding activity within postmortem plasma fractions.
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
